NCT03244280View on ClinicalTrials.gov

A Study of the Systemic Absorption of MOB015B

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 16, 2017

Primary Completion Date

April 23, 2018

Study Completion Date

April 23, 2018

Conditions

Onychomycosis

Interventions

DRUG

MOB015B

Topical formulation

Trial Locations (1)

78759

Dermatology clinic, Austin

Sponsors

Lead Sponsor

Moberg Pharma AB

All Listed Sponsors

lead

Moberg Pharma AB

INDUSTRY